Life science companies from Cambridge and London are off to San Francisco in the New Year to showcase their biotechnology ...
ACORD announced today the winner of the ACORD Student Challenge 2025, a first-of-its-kind national competition that empowers university students to leverage cutting-edge technology to optimize ...
Opinion
Outlook Business on MSNOpinion
Don't Ask for ₹100 Cr, Ask for ₹3 Cr: Why This Expert Wants Deep Tech Cos to Take One Step at a Time
India’s deep-tech journey needs smarter funding, stronger R&D and industry–academia collaboration. FSID’s Yogesh Pandit explains the gaps and the path to 2047 ...
While headlines focus on Harvard and Columbia, state universities train far more STEM students, power the nation’s research ...
From a Polynesian island ringed by blue lagoons to Chile's gaucho heartland, these are BBC journalists' top destinations this ...
Cambridgeshire Live readers are unhappy that ministers have approved plans to demolish the Beehive Centre in Cambridge, ...
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
Karnataka has recorded a steep decline in government school enrolment over the past 15 years, prompting the state to roll out ...
The World Economic Forum president and CEO spoke to CNN at the Doha Forum about how business, governments and innovators can unlock growth while tackling shared challenges.
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") , the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce ...
Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, H.C. Wainwright reiterated a Buy rating on Ocular Therapeutix Inc.
The Daily Galaxy on MSN
This tiny robot was lost for 8 months under Antarctica, now it’s back with unbelievable data
A small robotic float, lost for nearly nine months beneath Antarctica’s thick ice, has unexpectedly resurfaced—carrying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results